These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9854674)

  • 21. Cardiopulmonary bypass in humans: bypassing unfractionated heparin.
    Frederiksen JW
    Ann Thorac Surg; 2000 Oct; 70(4):1434-43. PubMed ID: 11081925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass.
    von Segesser LK
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):200-1. PubMed ID: 11174722
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery.
    Fromes Y; Daghildjian K; Caumartin L; Fischer M; Rouquette I; Deleuze P; Bical OM
    Anaesthesia; 2011 Jun; 66(6):488-92. PubMed ID: 21501130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Massive intracavitary clot formation during cardiopulmonary bypass.
    Legare JF; Arora R; Wood JW
    Can J Cardiol; 2004 Jun; 20(8):825-6. PubMed ID: 15229767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
    Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
    Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin during neonatal bypass.
    Kincaid K
    Perfusion; 2007 Mar; 22(2):143. PubMed ID: 17708164
    [No Abstract]   [Full Text] [Related]  

  • 27. No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
    Olsson C; Siegbahn A; Haldén E; Nilsson B; Venge P; Thelin S
    Ann Thorac Surg; 2000 Mar; 69(3):743-9. PubMed ID: 10750754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin allergy: successful desensitization for cardiopulmonary bypass.
    Parekh K; Burkhart HM; Hatab A; Ross A; Muller BA
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1455-6. PubMed ID: 16256803
    [No Abstract]   [Full Text] [Related]  

  • 29. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair.
    Gallagher JM; Brown ME; Gasior TA
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):728-30. PubMed ID: 8664469
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation.
    Kuitunen AH; Heikkilä LJ; Salmenperä MT
    Ann Thorac Surg; 1997 Feb; 63(2):438-44. PubMed ID: 9033316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparinless partial cardiopulmonary bypass for the repair of aortic trauma.
    Downing SW; Cardarelli MG; Sperling J; Attar S; Wallace DC; Rodriguez A; Brown J; Whitman GJ; McLaughlin JS
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1104-9; discussion 1110-1. PubMed ID: 11088034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboresistant cardiopulmonary bypass circuits: room for improvement?
    Poynter JA
    J Surg Res; 2010 Oct; 163(2):e51-2. PubMed ID: 20452618
    [No Abstract]   [Full Text] [Related]  

  • 35. Heparin-bonded circuit with low systemic anticoagulation in a patient with heparin-induced thrombocytopenia: a case report.
    O'Gara PJ; Aldea GS; Shemin RJ; Shapira OM
    J Extra Corpor Technol; 1999 Sep; 31(3):142-4. PubMed ID: 10847957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study.
    Aldea GS; Doursounian M; O'Gara P; Treanor P; Shapira OM; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1996 Aug; 62(2):410-7; discussion 417-8. PubMed ID: 8694599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More biocompatibility in cardiopulmonary bypass for high-risk patients.
    Baufreton C
    Ann Thorac Surg; 2006 Feb; 81(2):790-1; author reply 791. PubMed ID: 16427917
    [No Abstract]   [Full Text] [Related]  

  • 38. Pericardiectomy for constrictive pericarditis using a percutaneous heparin-coated cardiopulmonary support system.
    Saito A; Hirahara H; Ohzeki H; Hayashi J; Eguchi S
    Thorac Cardiovasc Surg; 1996 Dec; 44(6):311-2. PubMed ID: 9021910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effects of the heparin coated surface in cardiopulmonary bypass.
    Svenmarker S; Sandström E; Karlsson T; Jansson E; Häggmark S; Lindholm R; Appelblad M; Aberg T
    Eur J Cardiothorac Surg; 1997 May; 11(5):957-64. PubMed ID: 9196315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S; Mccusker K; Vijay V
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.